| 1 | 1/1 | 返回列表 |
| 查看: 630 | 回復: 0 | |||
ls_2018新蟲 (小有名氣)
|
[交流]
美國國立衛(wèi)生研究院(NIH)國家腫瘤中心(NCI)Chengkai Dai實驗室招聘博后
|
|
美國國立衛(wèi)生研究院(NIH)國家腫瘤中心(NCI)Chengkai Dai實驗室招聘博后 熱烈歡迎有興趣的同仁加入! Position Title: Elucidation of proteomic instability in cancer and the role of HSF1 in enabling oncogenesis. Position Description: Dr. Chengkai Dai’s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), USA has one postdoctoral fellowship (visiting fellow) position open. The candidates will participate in projects that elucidate proteomic instability of cancer and tumor-associated amyloidogenesis, new phenomena in cancer biology, and investigate the multifaceted pro-oncogenic roles of heat shock factor 1 (HSF1). HSF1, the master transcriptional regulator of the heat-shock or proteotoxic stress, response, plays a critical role in preserving proteomic stability under stress conditions. Contrasting with its dispensability for primary cells, cancerous cells become dependent on HSF1, a phenomenon referred to as “non-oncogene addiction”. Revealed by Project Achilles, numerous human cancer cell lines depend on HSF1. Dr. Dai’s laboratory is conducting interdisciplinary research in the emerging field of proteomic instability of cancer. His recent research reveals that amyloidogenesis, due to disruption of proteome homeostasis, is tumor-suppressive and that HSF1 plays a critical role in repressing amyloidogenesis (Cell. 2015, 160:729-44; Nature Cell Biology. 2016, 18:527-39; Molecular Cell. 2019, 76:546-561; Science Advances. 2020, 6:eabc6871). Detailed information about Dr. Dai’s research and publications can be accessed at https://ccr.cancer.gov/staff-directory/chengkai-dai. Candidates for the postdoctoral fellowship may have up to 4 years of postdoctoral training experience. NCI offers an outstanding environment for training and career development. Postdoctoral trainees in Dr. Dai’s lab have successfully competed for NCI career transition awards and secured independent faculty positions. Applications, sent by e-mail to Dr. Dai (chengkai.dai@nih.gov), Phone (301) 846-5227, should consist of a cover letter describing research experience and interests, curriculum vitae, bibliography, and contact information of three references. Employer Name: Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, DHHS. Position Location: National Cancer Institute – Frederick, Frederick, MD 21702 These positions are subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs. |
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[教師之家] 交大前校長王樹國:現(xiàn)在最先進的科技并不在大學實驗室,而是在企業(yè)研究院 +3 | zju2000 2026-03-08 | 4/200 |
|
|---|---|---|---|---|
|
[考研]
|
Sixuan wang 2026-03-06 | 7/350 |
|
|
[考博] 26申博自薦 +8 | 烷基八氮- 2026-03-06 | 10/500 |
|
|
[考研] 322分 085600求調(diào)劑,有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +4 | 熊境喆 2026-03-05 | 4/200 |
|
|
[考研] 化學290求調(diào)劑 +3 | 兩顆 西柚 2026-03-07 | 4/200 |
|
|
[考研] 一志愿中國石油大學(華東) 本科齊魯工業(yè)大學 求調(diào)劑 +3 | snw石 2026-03-07 | 3/150 |
|
|
[考研] 誠求調(diào)劑,323分 有專利/科研/實習經(jīng)歷 +6 | 橙子cyx 2026-03-06 | 8/400 |
|
|
[考研] 085600材料與化工(高分子)290分求調(diào)劑 +9 | wengyujian 2026-03-04 | 9/450 |
|
|
[考研] 材料調(diào)劑 +4 | L9370 2026-03-05 | 4/200 |
|
|
[考研] 求調(diào)劑 +3 | 泡了個椒 2026-03-04 | 4/200 |
|
|
[考研] 材料085600 303求調(diào)劑 +7 | 1bygone 2026-03-04 | 7/350 |
|
|
[考研] 0703化學 學碩 理工科均可 不區(qū)分研究方向 總分279求調(diào)劑 +7 | 1一11 2026-03-03 | 7/350 |
|
|
[考研] 材料與化工,291分,求調(diào)劑 +9 | 咕嚕咕嚕123123 2026-03-04 | 11/550 |
|
|
[考研] 070300化學 280 一志愿太原理工 求調(diào)劑 +8 | 拾玖壹 2026-03-04 | 8/400 |
|
|
[論文投稿]
100+4
|
Stray2021 2026-03-03 | 4/200 |
|
|
[考研] 307求調(diào)劑 +4 | xuyuan111 2026-03-04 | 5/250 |
|
|
[考研] 0703化學求調(diào)劑,總分320分,一志愿中南民族大學 +3 | 19286712440 2026-03-04 | 3/150 |
|
|
[考研] 284求調(diào)劑 +6 | 天下熯 2026-03-02 | 6/300 |
|
|
[考研] 275求調(diào)劑 +7 | 明遠求學 2026-03-01 | 7/350 |
|
|
[考研] 一志愿中石油(華東)本科齊魯工業(yè)大學 +3 | 石能偉 2026-03-02 | 3/150 |
|